Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 312

1.

Parametric modelling of cost data in medical studies.

Nixon RM, Thompson SG.

Stat Med. 2004 Apr 30;23(8):1311-31.

PMID:
15083485
2.

Semi-parametric modelling for costs of health care technologies.

Conigliani C, Tancredi A.

Stat Med. 2005 Oct 30;24(20):3171-84.

PMID:
15568210
3.

Parametric modelling of cost data: some simulation evidence.

Briggs A, Nixon R, Dixon S, Thompson S.

Health Econ. 2005 Apr;14(4):421-8.

PMID:
15685641
4.

Performance of statistical models to predict mental health and substance abuse cost.

Montez-Rath M, Christiansen CL, Ettner SL, Loveland S, Rosen AK.

BMC Med Res Methodol. 2006 Oct 26;6:53.

5.

Analysis of cost data in randomized trials: an application of the non-parametric bootstrap.

Barber JA, Thompson SG.

Stat Med. 2000 Dec 15;19(23):3219-36.

PMID:
11113956
6.

A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.

Kilian R, Matschinger H, Löeffler W, Roick C, Angermeyer MC.

J Ment Health Policy Econ. 2002 Mar;5(1):21-31.

PMID:
12529567
7.

Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared.

Nixon RM, Wonderling D, Grieve RD.

Health Econ. 2010 Mar;19(3):316-33. doi: 10.1002/hec.1477.

PMID:
19378353
8.

Bayesian estimation of cost-effectiveness from censored data.

Heitjan DF, Kim CY, Li H.

Stat Med. 2004 Apr 30;23(8):1297-309.

PMID:
15083484
10.

Generalisability in economic evaluation studies in healthcare: a review and case studies.

Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.

11.
12.

How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.

Lambert PC, Sutton AJ, Burton PR, Abrams KR, Jones DR.

Stat Med. 2005 Aug 15;24(15):2401-28.

PMID:
16015676
13.

Confidence intervals for cost-effectiveness ratios: a comparison of four methods.

Polsky D, Glick HA, Willke R, Schulman K.

Health Econ. 1997 May-Jun;6(3):243-52.

PMID:
9226142
14.

Comparison of Markov model and discrete-event simulation techniques for HIV.

Simpson KN, Strassburger A, Jones WJ, Dietz B, Rajagopalan R.

Pharmacoeconomics. 2009;27(2):159-65. doi: 10.2165/00019053-200927020-00006.

PMID:
19254048
16.
17.

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

Briggs AH, Wonderling DE, Mooney CZ.

Health Econ. 1997 Jul-Aug;6(4):327-40. Review.

PMID:
9285227
18.
19.

A study on confidence intervals for incremental cost-effectiveness ratios.

Wang H, Zhao H.

Biom J. 2008 Aug;50(4):505-14. doi: 10.1002/bimj.200810439.

PMID:
18663759
20.

Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results.

Tambour M, Zethraeus N.

Health Econ. 1998 Mar;7(2):143-7.

PMID:
9565170

Supplemental Content

Support Center